Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…s evaluating the delta-Renalase (periprocedural change in serum renalase) as a candidate association-based biomarker. Accordingly, this …
…th IMU. Among 117 drugs with positive signals for IMU in FAERS, brolucizumab (ROR 025=145.89, IC025=7.08), faricimab (ROR025=134.06, IC025=6…
…ongoing productive cough and wheeze. Despite a recent course of antibiotics, symptoms persisted. She was given a further course of antibiot…
…ect (adjusted HR 0.35, 95% CI 0.22 to 0.56, p<0.001) and use of inhaled corticosteroids (adjusted HR 0.64, 95% CI 0.43 to 0.93, p=0.020) were strongly …
…on the advice of Rheumatology.Fertility-related side effects of cyclophosphamide therapy were discussed with Gynaecology: a gonadotrophin releas…
…ccompanied by numbness, and shooting pains who was treated with cyclophosphamide and prednisolone at local hospital for a possible vasculitis. N…
… serious complication of tuberculous meningitis. Treatment with dexamethasone can reduce complication rates by reducing spinal inflammation. …
…Cladribine tablets, a highly effective (DMT), have been available in UK si…
…( NCT03972306) and II (NCT05232825) show that subcutaneous (SC) ocrelizumab (OCR) 920 mg has a similar benefit-risk profile to intravenous …
… 0.89 – survey-cohort).Conclusion We demonstrate the utility of EQ-5D-5L to appraise HRQoL in the UK FSHD patients. EQ-5D-5L health util…
…s TRAILRUNNER-ALZ3 (TR3; NCT06653153) tests the hypothesis that remternetug treatment will delay clinical progression of Alzheimer’s diseas…
…rogressive MS (SPMS) currently has limited therapeutic options. Siponimod, a sphingosine-1-phosphate receptor modulator, prevents lymphoc…